Identification of neoantigen-specific T cell responses in cancer patients within the Penn Medicine BioBank

  • STATUS
    Enrolling By Invitation
Updated on 19 February 2024

Summary

You are being asked to participate in this research investigation because you have expressed an interest in participating in a study to better understand how the immune cells of the body recognize and fight cancer.

Description

The main purpose of this study is to identify immune fighting cells known as T cells that recognize proteins expressed by cancer cells. The results of this study will be used to develop new treatments for cancer patients using the body’s immune system. The study involves providing a blood sample to be used in the laboratory for immune system research at the University of Pennsylvania. Your cells will be collected and purified by members of the Vonderheide lab. Your immune cells known as white blood cells will be analyzed to determine your Human Leukocyte Antigen (HLA) type. HLA is a unique genetic marker or “fingerprint” on white blood cells that are important for how your immune system fights infections and cancer. Your white blood cells will then be used in the laboratory to study how the cells of the immune system recognize and kill cancer cells. No experimental treatments or procedures will be performed on you. These research results will not be of direct benefit to you, however, the results may provide important benefits to patients with cancer in the future. With this in mind, you are being asked to serve as a volunteer to donate white blood cells for this research study.

FAQ


Details
Condition cancer
Age 18years - 90years
Clinical Study IdentifierTX6312
Last Modified on19 February 2024

Eligibility

If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.